Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas : local therapeutic effect and 5-year survival rate
The local therapeutic effects and 5-year survival rates obtained following subsegmental transcatheter arterial embolization (TAE) therapy for small hepatocellular carcinomas (HCCs) were retrospectively analyzed. A total of 124 nodular-type HCC lesions measuring less than 4 cm in diameter in 100 pati...
Gespeichert in:
| Veröffentlicht in: | Cancer chemotherapy and pharmacology 1994-01, Vol.33 (S1), p.S84-S88 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | S88 |
|---|---|
| container_issue | S1 |
| container_start_page | S84 |
| container_title | Cancer chemotherapy and pharmacology |
| container_volume | 33 |
| creator | MATSUI, O KADOYA, M YSOHIKAWA, J GABATA, T TAKASHIMA, T DEMACHI, H |
| description | The local therapeutic effects and 5-year survival rates obtained following subsegmental transcatheter arterial embolization (TAE) therapy for small hepatocellular carcinomas (HCCs) were retrospectively analyzed. A total of 124 nodular-type HCC lesions measuring less than 4 cm in diameter in 100 patients with liver cirrhosis were subjected to the analysis. All lesions became opaque on digital subtraction angiography. Complete necrosis was seen in 64% of 11 resected lesions. Among the remaining 113 lesions, the 1- and 5-year local recurrence rates following one performance of TAE were 18% and 33%, respectively. The 1- and 5-year survival rates were 100% and 53%, respectively. No significant side effect was observed after TAE therapy. Subsegmental TAE therapy significantly improved the long-term survival rates of patients with small HCCs associated with liver cirrhosis as compared with those treated by conventional TAE therapy. |
| doi_str_mv | 10.1007/bf00686674 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76406266</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76406266</sourcerecordid><originalsourceid>FETCH-LOGICAL-c377t-83a4c2b7823b4f88b760c558232faa193bd62bf6f24a166c503315a92995aa9a3</originalsourceid><addsrcrecordid>eNo9kEFvFCEUx4mpWbfVi3cTDk0PJlNhYGDGW7ux2qSJB_U8ebAPF8MMKzBN6ifox5ZNt73wAu_3_i_8CHnP2SVnTH8yjjHVK6XlK7LmUrQN66U4IWsmpGw6zeQbcprzH8aY5EKsyKrnQsuBrcnjj8Vk_D3hXCDQkmDOFsoOCyYKqZ6-PuNkYvD_oPg4UxcTzROEQHe4hxIthrAESNRCsn6OE2T6mYZoD3k7TLDHpXhL0Tm0hcK8pV3zgHUgL-ne31csQcG35LWDkPHdsZ6RXzdffm6-NXffv95uru4aK7QuTS9A2tbovhVGur43WjHbdfXaOgA-CLNVrXHKtRK4UrZjQvAOhnYYOoABxBm5eMrdp_h3wVzGyefDH2DGuORRK8lUq1QFPz6BNsWcE7pxn_wE6WHkbDxoH69vnrVX-MMxdTETbl_Qo-faPz_2ofoNrnq2Pr9gYqhLuRb_ARGqjAM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76406266</pqid></control><display><type>article</type><title>Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas : local therapeutic effect and 5-year survival rate</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>MATSUI, O ; KADOYA, M ; YSOHIKAWA, J ; GABATA, T ; TAKASHIMA, T ; DEMACHI, H</creator><creatorcontrib>MATSUI, O ; KADOYA, M ; YSOHIKAWA, J ; GABATA, T ; TAKASHIMA, T ; DEMACHI, H</creatorcontrib><description>The local therapeutic effects and 5-year survival rates obtained following subsegmental transcatheter arterial embolization (TAE) therapy for small hepatocellular carcinomas (HCCs) were retrospectively analyzed. A total of 124 nodular-type HCC lesions measuring less than 4 cm in diameter in 100 patients with liver cirrhosis were subjected to the analysis. All lesions became opaque on digital subtraction angiography. Complete necrosis was seen in 64% of 11 resected lesions. Among the remaining 113 lesions, the 1- and 5-year local recurrence rates following one performance of TAE were 18% and 33%, respectively. The 1- and 5-year survival rates were 100% and 53%, respectively. No significant side effect was observed after TAE therapy. Subsegmental TAE therapy significantly improved the long-term survival rates of patients with small HCCs associated with liver cirrhosis as compared with those treated by conventional TAE therapy.</description><identifier>ISSN: 0344-5704</identifier><identifier>EISSN: 1432-0843</identifier><identifier>DOI: 10.1007/bf00686674</identifier><identifier>PMID: 8137490</identifier><identifier>CODEN: CCPHDZ</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Adult ; Aged ; Antineoplastic agents ; Biological and medical sciences ; Carcinoma, Hepatocellular - complications ; Carcinoma, Hepatocellular - diagnostic imaging ; Carcinoma, Hepatocellular - therapy ; Chemoembolization, Therapeutic ; Chemotherapy ; Female ; Follow-Up Studies ; Humans ; Liver Cirrhosis - complications ; Liver Neoplasms - complications ; Liver Neoplasms - diagnostic imaging ; Liver Neoplasms - therapy ; Male ; Medical sciences ; Middle Aged ; Necrosis ; Neoplasm Recurrence, Local ; Pharmacology. Drug treatments ; Radiography ; Retrospective Studies ; Survival Rate</subject><ispartof>Cancer chemotherapy and pharmacology, 1994-01, Vol.33 (S1), p.S84-S88</ispartof><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c377t-83a4c2b7823b4f88b760c558232faa193bd62bf6f24a166c503315a92995aa9a3</citedby><cites>FETCH-LOGICAL-c377t-83a4c2b7823b4f88b760c558232faa193bd62bf6f24a166c503315a92995aa9a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,780,784,789,790,23929,23930,25139,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3940617$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8137490$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MATSUI, O</creatorcontrib><creatorcontrib>KADOYA, M</creatorcontrib><creatorcontrib>YSOHIKAWA, J</creatorcontrib><creatorcontrib>GABATA, T</creatorcontrib><creatorcontrib>TAKASHIMA, T</creatorcontrib><creatorcontrib>DEMACHI, H</creatorcontrib><title>Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas : local therapeutic effect and 5-year survival rate</title><title>Cancer chemotherapy and pharmacology</title><addtitle>Cancer Chemother Pharmacol</addtitle><description>The local therapeutic effects and 5-year survival rates obtained following subsegmental transcatheter arterial embolization (TAE) therapy for small hepatocellular carcinomas (HCCs) were retrospectively analyzed. A total of 124 nodular-type HCC lesions measuring less than 4 cm in diameter in 100 patients with liver cirrhosis were subjected to the analysis. All lesions became opaque on digital subtraction angiography. Complete necrosis was seen in 64% of 11 resected lesions. Among the remaining 113 lesions, the 1- and 5-year local recurrence rates following one performance of TAE were 18% and 33%, respectively. The 1- and 5-year survival rates were 100% and 53%, respectively. No significant side effect was observed after TAE therapy. Subsegmental TAE therapy significantly improved the long-term survival rates of patients with small HCCs associated with liver cirrhosis as compared with those treated by conventional TAE therapy.</description><subject>Adult</subject><subject>Aged</subject><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Hepatocellular - complications</subject><subject>Carcinoma, Hepatocellular - diagnostic imaging</subject><subject>Carcinoma, Hepatocellular - therapy</subject><subject>Chemoembolization, Therapeutic</subject><subject>Chemotherapy</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Liver Cirrhosis - complications</subject><subject>Liver Neoplasms - complications</subject><subject>Liver Neoplasms - diagnostic imaging</subject><subject>Liver Neoplasms - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Necrosis</subject><subject>Neoplasm Recurrence, Local</subject><subject>Pharmacology. Drug treatments</subject><subject>Radiography</subject><subject>Retrospective Studies</subject><subject>Survival Rate</subject><issn>0344-5704</issn><issn>1432-0843</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEFvFCEUx4mpWbfVi3cTDk0PJlNhYGDGW7ux2qSJB_U8ebAPF8MMKzBN6ifox5ZNt73wAu_3_i_8CHnP2SVnTH8yjjHVK6XlK7LmUrQN66U4IWsmpGw6zeQbcprzH8aY5EKsyKrnQsuBrcnjj8Vk_D3hXCDQkmDOFsoOCyYKqZ6-PuNkYvD_oPg4UxcTzROEQHe4hxIthrAESNRCsn6OE2T6mYZoD3k7TLDHpXhL0Tm0hcK8pV3zgHUgL-ne31csQcG35LWDkPHdsZ6RXzdffm6-NXffv95uru4aK7QuTS9A2tbovhVGur43WjHbdfXaOgA-CLNVrXHKtRK4UrZjQvAOhnYYOoABxBm5eMrdp_h3wVzGyefDH2DGuORRK8lUq1QFPz6BNsWcE7pxn_wE6WHkbDxoH69vnrVX-MMxdTETbl_Qo-faPz_2ofoNrnq2Pr9gYqhLuRb_ARGqjAM</recordid><startdate>199401</startdate><enddate>199401</enddate><creator>MATSUI, O</creator><creator>KADOYA, M</creator><creator>YSOHIKAWA, J</creator><creator>GABATA, T</creator><creator>TAKASHIMA, T</creator><creator>DEMACHI, H</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199401</creationdate><title>Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas : local therapeutic effect and 5-year survival rate</title><author>MATSUI, O ; KADOYA, M ; YSOHIKAWA, J ; GABATA, T ; TAKASHIMA, T ; DEMACHI, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c377t-83a4c2b7823b4f88b760c558232faa193bd62bf6f24a166c503315a92995aa9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Hepatocellular - complications</topic><topic>Carcinoma, Hepatocellular - diagnostic imaging</topic><topic>Carcinoma, Hepatocellular - therapy</topic><topic>Chemoembolization, Therapeutic</topic><topic>Chemotherapy</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Liver Cirrhosis - complications</topic><topic>Liver Neoplasms - complications</topic><topic>Liver Neoplasms - diagnostic imaging</topic><topic>Liver Neoplasms - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Necrosis</topic><topic>Neoplasm Recurrence, Local</topic><topic>Pharmacology. Drug treatments</topic><topic>Radiography</topic><topic>Retrospective Studies</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MATSUI, O</creatorcontrib><creatorcontrib>KADOYA, M</creatorcontrib><creatorcontrib>YSOHIKAWA, J</creatorcontrib><creatorcontrib>GABATA, T</creatorcontrib><creatorcontrib>TAKASHIMA, T</creatorcontrib><creatorcontrib>DEMACHI, H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer chemotherapy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MATSUI, O</au><au>KADOYA, M</au><au>YSOHIKAWA, J</au><au>GABATA, T</au><au>TAKASHIMA, T</au><au>DEMACHI, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas : local therapeutic effect and 5-year survival rate</atitle><jtitle>Cancer chemotherapy and pharmacology</jtitle><addtitle>Cancer Chemother Pharmacol</addtitle><date>1994-01</date><risdate>1994</risdate><volume>33</volume><issue>S1</issue><spage>S84</spage><epage>S88</epage><pages>S84-S88</pages><issn>0344-5704</issn><eissn>1432-0843</eissn><coden>CCPHDZ</coden><abstract>The local therapeutic effects and 5-year survival rates obtained following subsegmental transcatheter arterial embolization (TAE) therapy for small hepatocellular carcinomas (HCCs) were retrospectively analyzed. A total of 124 nodular-type HCC lesions measuring less than 4 cm in diameter in 100 patients with liver cirrhosis were subjected to the analysis. All lesions became opaque on digital subtraction angiography. Complete necrosis was seen in 64% of 11 resected lesions. Among the remaining 113 lesions, the 1- and 5-year local recurrence rates following one performance of TAE were 18% and 33%, respectively. The 1- and 5-year survival rates were 100% and 53%, respectively. No significant side effect was observed after TAE therapy. Subsegmental TAE therapy significantly improved the long-term survival rates of patients with small HCCs associated with liver cirrhosis as compared with those treated by conventional TAE therapy.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>8137490</pmid><doi>10.1007/bf00686674</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0344-5704 |
| ispartof | Cancer chemotherapy and pharmacology, 1994-01, Vol.33 (S1), p.S84-S88 |
| issn | 0344-5704 1432-0843 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_76406266 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Adult Aged Antineoplastic agents Biological and medical sciences Carcinoma, Hepatocellular - complications Carcinoma, Hepatocellular - diagnostic imaging Carcinoma, Hepatocellular - therapy Chemoembolization, Therapeutic Chemotherapy Female Follow-Up Studies Humans Liver Cirrhosis - complications Liver Neoplasms - complications Liver Neoplasms - diagnostic imaging Liver Neoplasms - therapy Male Medical sciences Middle Aged Necrosis Neoplasm Recurrence, Local Pharmacology. Drug treatments Radiography Retrospective Studies Survival Rate |
| title | Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas : local therapeutic effect and 5-year survival rate |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T19%3A46%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Subsegmental%20transcatheter%20arterial%20embolization%20for%20small%20hepatocellular%20carcinomas%20:%20local%20therapeutic%20effect%20and%205-year%20survival%20rate&rft.jtitle=Cancer%20chemotherapy%20and%20pharmacology&rft.au=MATSUI,%20O&rft.date=1994-01&rft.volume=33&rft.issue=S1&rft.spage=S84&rft.epage=S88&rft.pages=S84-S88&rft.issn=0344-5704&rft.eissn=1432-0843&rft.coden=CCPHDZ&rft_id=info:doi/10.1007/bf00686674&rft_dat=%3Cproquest_cross%3E76406266%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76406266&rft_id=info:pmid/8137490&rfr_iscdi=true |